Panels, Mini-Panels and Study Groups
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
EAZA Best Practice Guidelines Bonobo (Pan Paniscus)
EAZA Best Practice Guidelines Bonobo (Pan paniscus) Editors: Dr Jeroen Stevens Contact information: Royal Zoological Society of Antwerp – K. Astridplein 26 – B 2018 Antwerp, Belgium Email: [email protected] Name of TAG: Great Ape TAG TAG Chair: Dr. María Teresa Abelló Poveda – Barcelona Zoo [email protected] Edition: First edition - 2020 1 2 EAZA Best Practice Guidelines disclaimer Copyright (February 2020) by EAZA Executive Office, Amsterdam. All rights reserved. No part of this publication may be reproduced in hard copy, machine-readable or other forms without advance written permission from the European Association of Zoos and Aquaria (EAZA). Members of the European Association of Zoos and Aquaria (EAZA) may copy this information for their own use as needed. The information contained in these EAZA Best Practice Guidelines has been obtained from numerous sources believed to be reliable. EAZA and the EAZA APE TAG make a diligent effort to provide a complete and accurate representation of the data in its reports, publications, and services. However, EAZA does not guarantee the accuracy, adequacy, or completeness of any information. EAZA disclaims all liability for errors or omissions that may exist and shall not be liable for any incidental, consequential, or other damages (whether resulting from negligence or otherwise) including, without limitation, exemplary damages or lost profits arising out of or in connection with the use of this publication. Because the technical information provided in the EAZA Best Practice Guidelines can easily be misread or misinterpreted unless properly analysed, EAZA strongly recommends that users of this information consult with the editors in all matters related to data analysis and interpretation. -
The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands
The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands Clare Louise Wishart Submitted in accordance with the requirements for the degree of Doctor of Philosophy of Science University of Leeds School of Biomedical Sciences Faculty of Biological Sciences September 2013 I Intellectual Property and Publication Statements The candidate confirms that the work submitted is her own and that appropriate credit has been given where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. The right of Clare Louise Wishart to be identified as Author of this work has been asserted by her in accordance with the Copyright, Designs and Patents Act 1988. © 2013 The University of Leeds and Clare Louise Wishart. II Acknowledgments Firstly I would like to offer my sincerest thanks and gratitude to my supervisor, Dr. Dan Donnelly, who has been nothing but encouraging and engaging from day one. I have thoroughly enjoyed every moment of working alongside him and learning from his guidance and wisdom. My thanks go to my academic assessor Professor Paul Milner whom I have known for several years, and during my time at the University of Leeds he has offered me invaluable advice and inspiration. Additionally I would like to thank my academic project advisor Dr. Michael Harrison for his friendship, help and advice. I would like to thank Dr. Rosalind Mann and Dr. Elsayed Nasr for welcoming me into the lab as a new PhD student and sharing their experimental techniques with me, these techniques have helped me no end in my time as a research student. -
Receptor Internalization Assays
REF: P30214 RECEPTOR INTERNALIZATION ASSAYS - PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE TYPE I RECEPTOR - Product name: ADCYAP1R1-tGFP (PAC1-tGFP) / U2OS cell line -7 Ec50 PACAP-38: 1.06 x 10 M Z´: 0.73+/- 0.02 INNOVATIVE TECHNOLOGIES IN BIOLOGICAL SYSTEMS, S.L. Parque Tecnológico Bizkaia, Edifício 502, 1ª Planta | 48160 | Derio | Bizkaia Tel.: +34 944005355 | Fax: +34 946579925 VAT No. [email protected] | www.innoprot.com ESB95481909 Product Name: ADCYAP1R1-tGFP_U2OS Reference: P30214 Rep. Official Full Name: Pituitary adenylate cyclase- activating polypeptide type I receptor DNA Accession Number: Gene Bank AY366498 Host Cell: U2OS References: P30214: 2 vials of 3 x 106 proliferative cells P30214-DA: 1 vial of 2 x 106 division-arrested cells Storage: Liquid Nitrogen Assay Briefly description About ADCYAP1R1 Each vial of ADCYAP1R1 Internalization Assay Pituitary adenylate cyclase-activating Cell Line contains U2OS cells stably expressing polypeptide type I receptor, also known as human Pituitary adenylate cyclase-activating PAC1 is a protein that in humans is encoded by polypeptide type I receptor tagged in the N- the ADCYAP1R1 gene. ADCYAP1R1 is a terminus with tGFP protein. membrane-associated protein and shares significant homology with members of the Innoprot’s ADCYAP1R1-tGFP Internalization glucagon/secretin receptor family. This receptor Assay Cell Line has been designed to assay binds pituitary adenylate cyclase activating potential agonists/ antagonists against peptide (PACAP) mediating several biological ADCYAP1R1, modulating its activation and the activities and it is positively coupled to following redistribution process inside the cells. adenylate cyclase. This cell line will allow the image analysis of the stimuli induced by the compounds. -
Section 1: MIT Facts and History
1 MIT Facts and History Economic Information 9 Technology Licensing Office 9 People 9 Students 10 Undergraduate Students 11 Graduate Students 12 Degrees 13 Alumni 13 Postdoctoral Appointments 14 Faculty and Staff 15 Awards and Honors of Current Faculty and Staff 16 Awards Highlights 17 Fields of Study 18 Research Laboratories, Centers, and Programs 19 Academic and Research Affiliations 20 Education Highlights 23 Research Highlights 26 7 MIT Facts and History The Massachusetts Institute of Technology is one nologies for artificial limbs, and the magnetic core of the world’s preeminent research universities, memory that enabled the development of digital dedicated to advancing knowledge and educating computers. Exciting areas of research and education students in science, technology, and other areas of today include neuroscience and the study of the scholarship that will best serve the nation and the brain and mind, bioengineering, energy, the envi- world. It is known for rigorous academic programs, ronment and sustainable development, informa- cutting-edge research, a diverse campus commu- tion sciences and technology, new media, financial nity, and its long-standing commitment to working technology, and entrepreneurship. with the public and private sectors to bring new knowledge to bear on the world’s great challenges. University research is one of the mainsprings of growth in an economy that is increasingly defined William Barton Rogers, the Institute’s founding pres- by technology. A study released in February 2009 ident, believed that education should be both broad by the Kauffman Foundation estimates that MIT and useful, enabling students to participate in “the graduates had founded 25,800 active companies. -
Sten Grillner
BK-SFN-HON_V9-160105-Grillner.indd 108 5/6/2016 4:11:20 PM Sten Grillner BORN: Stockholm, Sweden June 14, 1941 EDUCATION: University of Göteborg, Sweden, Med. Candidate (1962) University of Göteborg, Sweden, Dr. of Medicine, PhD (1969) Academy of Science, Moscow, Visiting Scientist (1971) APPOINTMENTS: Docent in Physiology, Medical Faculty, University of Göteborg (1969–1975) Professor, Department of Physiology III, Karolinska Institute (1975–1986) Director, Nobel Institute for Neurophysiology, Karolinska Institute, Professor (1987) Nobel Committee for Physiology or Medicine, Chair, 1995–1997 (1987–1998) Nobel Assembly at the Karolinska Institutet, Member Chair, 2005 (1988–2008) Chairman Department of Neuroscience, Karolinska Institutet (1993–2000) Distinguished Professor, Karolinska Institutet (2010) HONORS AND AWARDS: Member of Academiae Europaea 1990– Member of Royal Swedish Academy of Science 1993– Chairman Section for Biology and Member of Academy Board, 2004–2010 Member of Norwegian Academy of Science and Letters, 1997– Member American Academy of Arts and Sciences, 2004– Honorary Member of the Spanish Medical Academy, 2006– Foreign Associate of Institute of Medicine of the National Academy, United States, 2006– Foreign Associate of the National Academy, United States, 2010– Associate of the Neuroscience Institute, La Jolla, 1989– Member EMBO, 2014– Florman Award, Royal Swedish Academy of Science, 1977 Grass Lecturer to the Society of Neuroscience, Boston, 1983 Greater Nordic Prize of Eric Fernstrom, Lund, Sweden, 1990 Bristol-Myers -
Reproductive Suppression and Alloparenting in Laboratory Mice
Two of a Kind or a Full House? Reproductive Suppression and Alloparenting in Laboratory Mice The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Garner, Joseph P., Brianna N. Gaskill, and Kathleen R. Pritchett- Corning. 2016. “Two of a Kind or a Full House? Reproductive Suppression and Alloparenting in Laboratory Mice.” PLoS ONE 11 (5): e0154966. doi:10.1371/journal.pone.0154966. http:// dx.doi.org/10.1371/journal.pone.0154966. Published Version doi:10.1371/journal.pone.0154966 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320428 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA RESEARCH ARTICLE Two of a Kind or a Full House? Reproductive Suppression and Alloparenting in Laboratory Mice Joseph P. Garner1, Brianna N. Gaskill2,3, Kathleen R. Pritchett-Corning2,4* 1 Stanford University, Department of Comparative Medicine, and by courtesy, Department of Psychiatry and Behavioral Sciences, Stanford, California, United States of America, 2 Charles River, Wilmington, Massachusetts, United States of America, 3 Purdue University Department of Comparative Pathobiology, West Lafayette, Indiana, United States of America, 4 Harvard University Faculty of Arts and Sciences, Office of Animal Resources, Cambridge, Massachusetts, United States of America a11111 * [email protected] Abstract Alloparenting, a behavior in which individuals other than the actual parents act in a parental role, is seen in many mammals, including house mice. -
The Brain That Changes Itself
The Brain That Changes Itself Stories of Personal Triumph from the Frontiers of Brain Science NORMAN DOIDGE, M.D. For Eugene L. Goldberg, M.D., because you said you might like to read it Contents 1 A Woman Perpetually Falling . Rescued by the Man Who Discovered the Plasticity of Our Senses 2 Building Herself a Better Brain A Woman Labeled "Retarded" Discovers How to Heal Herself 3 Redesigning the Brain A Scientist Changes Brains to Sharpen Perception and Memory, Increase Speed of Thought, and Heal Learning Problems 4 Acquiring Tastes and Loves What Neuroplasticity Teaches Us About Sexual Attraction and Love 5 Midnight Resurrections Stroke Victims Learn to Move and Speak Again 6 Brain Lock Unlocked Using Plasticity to Stop Worries, OPsessions, Compulsions, and Bad Habits 7 Pain The Dark Side of Plasticity 8 Imagination How Thinking Makes It So 9 Turning Our Ghosts into Ancestors Psychoanalysis as a Neuroplastic Therapy 10 Rejuvenation The Discovery of the Neuronal Stem Cell and Lessons for Preserving Our Brains 11 More than the Sum of Her Parts A Woman Shows Us How Radically Plastic the Brain Can Be Appendix 1 The Culturally Modified Brain Appendix 2 Plasticity and the Idea of Progress Note to the Reader All the names of people who have undergone neuroplastic transformations are real, except in the few places indicated, and in the cases of children and their families. The Notes and References section at the end of the book includes comments on both the chapters and the appendices. Preface This book is about the revolutionary discovery that the human brain can change itself, as told through the stories of the scientists, doctors, and patients who have together brought about these astonishing transformations. -
Cold Spring Harbor Symposia on Quantitative Biology, Volume LXXIX: Cognition
This is a free sample of content from Cold Spring Harbor Symposia on Quantitative Biology, Volume LXXIX: Cognition. Click here for more information on how to buy the book. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY VOLUME LXXIX Cognition symposium.cshlp.org Symposium organizers and Proceedings editors: Cori Bargmann (The Rockefeller University), Daphne Bavelier (University of Geneva, Switzerland, and University of Rochester), Terrence Sejnowski (The Salk Institute for Biological Studies), and David Stewart and Bruce Stillman (Cold Spring Harbor Laboratory) COLD SPRING HARBOR LABORATORY PRESS 2014 © 2014 by Cold Spring Harbor Laboratory Press. All rights reserved. This is a free sample of content from Cold Spring Harbor Symposia on Quantitative Biology, Volume LXXIX: Cognition. Click here for more information on how to buy the book. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY VOLUME LXXIX # 2014 by Cold Spring Harbor Laboratory Press International Standard Book Number 978-1-621821-26-7 (cloth) International Standard Book Number 978-1-621821-27-4 (paper) International Standard Serial Number 0091-7451 Library of Congress Catalog Card Number 34-8174 Printed in the United States of America All rights reserved COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY Founded in 1933 by REGINALD G. HARRIS Director of the Biological Laboratory 1924 to 1936 Previous Symposia Volumes I (1933) Surface Phenomena XXXIX (1974) Tumor Viruses II (1934) Aspects of Growth XL (1975) The Synapse III (1935) Photochemical Reactions XLI (1976) Origins -
Curriculum Vitae
Linda Wilbrecht Department of Psychology Phone: +1 (510) 600–3560 Helen Wills Neuroscience Institute Email: [email protected] University of California, Berkeley Web: https://wilbrecht.org 2121 Berkeley Way West Pubmed: Wilbrecht L Berkeley, CA 94720-1650 ORCID: 0000-0003-3492-8141 Education 2007–2008 Postdoctoral Fellow, University of California, San Francisco Advisor: Michael Merzenich, Ph.D., UCSF 2003–2006 Postdoctoral Fellow, Cold Spring Harbor Laboratory, NY Advisor: Karel Svoboda, Ph.D., HHMI/Cold Spring Harbor, NY 1997–2003 Ph.D. The Rockefeller University, NY Advisor: Fernando Nottebohm, Ph.D.,Lab of Animal Behavior 1995–1997 B.A., with honours, University of Oxford, UK Experimental Psychology and Philosophy 1993–1994 Visiting student, University of Oxford, St. Catherine’s College, UK Studied social sciences with Drs. Avner Ofer and Paul Weindling 1990–1995 B.A. summa cum laude, University of Minnesota, Twin Cities Department of Cultural Studies and Comparative Literature Appointments 2015–present Associate Professor, Department of Psychology Helen Wills Neuroscience Institute, UC Berkeley 2013–2015 Assistant Professor, Department of Psychology Helen Wills Neuroscience Institute, UC Berkeley 2008–2013 Assistant Professor in Residence, Department of Neurology UC San Francisco Principal Investigator, Ernest Gallo Clinic and Research Center, Emeryville, CA Linda Wilbrecht CV October 2019 Honors and awards 2019–2020 Miller Professor, UC Berkeley Miller Institute 2011 Presidential Early Career Award for Scientists and Engineers (PECASE) -
2010 Buenos Aires, Argentina
Claiming CME Credit To claim CME credit for your participation in the MDS 14th Credit Designation International Congress of Parkinson’s Disease and Movement The Movement Disorder Society designates this educational Disorders, International Congress participants must complete activity for a maximum of 35 AMA PRA Category 1 Credits™. and submit an online CME Request Form. This form will be Physicians should only claim credit commensurate with the available beginning June 15. extent of their participation in the activity. Instructions for claiming credit: If you need a Non-CME Certificate of Attendance, please tear • After June 15, visit the MDS Web site. out the Certificate in the back of this Program and write in • Log in after reading the instructions on the page. You will your name. need your International Congress File Number which is located on your name badge or e-mail The Movement Disorder Society has sought accreditation from [email protected]. the European Accreditation Council for Continuing Medical • Follow the on-screen instructions to claim CME Credit for Education (EACCME) to provide CME activity for medical the sessions you attended. specialists. The EACCME is an institution of the European • You may print your certificate from your home or office, or Union of Medical Specialists (UEMS). For more information, save it as a PDF for your records. visit the Web site: www.uems.net. Continuing Medical Education EACCME credits are recognized by the American Medical The Movement Disorder Society is accredited by the Association towards the Physician’s Recognition Award (PRA). Accreditation Council for Continuing Medical Education To convert EACCME credit to AMA PRA category 1 credit, (ACCME) to provide continuing medical education for contact the AMA online at www.ama-assn.org. -
Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes
Tohoku J. Exp. Med., 2011,Differential 223, 161-176 Gene Expression in OPCs, Oligodendrocytes and Type II Astrocytes 161 Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes Jian-Guo Hu,1,2,* Yan-Xia Wang,3,* Jian-Sheng Zhou,2 Chang-Jie Chen,4 Feng-Chao Wang,1 Xing-Wu Li1 and He-Zuo Lü1,2 1Department of Clinical Laboratory Science, The First Affiliated Hospital of Bengbu Medical College, Bengbu, P.R. China 2Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, P.R. China 3Department of Neurobiology, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China 4Department of Laboratory Medicine, Bengbu Medical College, Bengbu, P.R. China Oligodendrocyte precursor cells (OPCs) are bipotential progenitor cells that can differentiate into myelin-forming oligodendrocytes or functionally undetermined type II astrocytes. Transplantation of OPCs is an attractive therapy for demyelinating diseases. However, due to their bipotential differentiation potential, the majority of OPCs differentiate into astrocytes at transplanted sites. It is therefore important to understand the molecular mechanisms that regulate the transition from OPCs to oligodendrocytes or astrocytes. In this study, we isolated OPCs from the spinal cords of rat embryos (16 days old) and induced them to differentiate into oligodendrocytes or type II astrocytes in the absence or presence of 10% fetal bovine serum, respectively. RNAs were extracted from each cell population and hybridized to GeneChip with 28,700 rat genes. Using the criterion of fold change > 4 in the expression level, we identified 83 genes that were up-regulated and 89 genes that were down-regulated in oligodendrocytes, and 92 genes that were up-regulated and 86 that were down-regulated in type II astrocytes compared with OPCs. -
MONOCLONAL ANTI-VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1 (VIPR 1, VPAC1) Clone AS58 Purified Mouse Immunoglobulin
MONOCLONAL ANTI-VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1 (VIPR 1, VPAC1) Clone AS58 Purified Mouse Immunoglobulin Product Number V1631 Product Description Although structurally related, VIPR1 and VIPR2 exhibit Monoclonal Anti-Vasoactive Intestinal Peptide differences in expression and function and VIP has a Receptor 1 (VIPR1) (mouse IgG2a isotype) is derived 3-10 fold preference for VIPR1 over VIPR2 receptors. from the hybridoma produced by the fusion of mouse myeloma cells and splenocytes from a BALB/c mouse VIPR1 is expressed throughout the central nervous immunized with a unique peptide corresponding to a system (predominantly in the cerebral cortex and portion of human Vasoactive Intestinal Peptide hippocampus), in peripheral tissues including liver, lung Receptor 1 (VIPR1). The antibody was purified from and intestine and in T lymphocytes.14 VIPR1 mediates tissue culture supernatant using immobilized Protein G. suppression of chemotaxis and matrix metalloprotein- ase expression elicited by some cytokines and chemo- Monoclonal Anti-Vasoactive Intestinal Peptide kines, tumor cell migration induced by VIP, and vaso- Receptor 1 (VIPR1) recognizes VIPR1 protein from dilation. human and rat tissue by immunoblotting and by flow cytometric analysis of human cells using indirect VIPR2 is expressed throughout the central nervous immunofluorescence. The antibody does not recognize system, but to varying degrees. The highest expression VIPR2 protein. levels are in the thalamus and suprachiasmatic nucleus, but VIPR2 is also present in the hippocampus,